St. Jude Medical CEO Daniel Starks said he believes the company will continue to experience sales growth, driven by new pacemakers and other cardiac-rhythm management devices that are designed to treat atrial fibrillation. The company said it has sufficient cash to buy back shares and acquire companies.

Full Story:

Related Summaries